Kidney graft survival in patients with hepatitis C: A single center experience

Clinical Transplantation

Volumn 22, Issue 1, 2008, Pages 16-19

  Arango, Jorge L ^a   Arbelaez, M ^a   Henao, J ^a   Mejia, G ^a   Arroyave, I ^a   Carvajal, J ^a   Garcia, A ^a   Gutierrez, J ^a   Velasquez A ^a   Garcia, L ^a   Aguirre, C ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b Grupo de Neurociencias de Antioquia   (Colombia)

Author keywords

Deceased donor; Hepatitis C; Living related donor; Renal transplantation survival

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CADAVER KIDNEY; CHILD; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODIALYSIS; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CYCLOSPORINE; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 38549150849     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00679.x     Document Type: Article

References (17)

1. Hayashi J, Nakashima K, Kajyana W. Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 1991: 134: 651.
2. Knudsen F, Wantzin P, Rasmussen K. Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993: 43: 1353.
3. Lin DY, Lin HH, Huan CC. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993: 3: 288.
4. Mitwalli A, Al-Mohaya S, Al Wakeel J. Hepatitis C in chronic renal failure patients. Am J Nephrol 1992: 12: 288.
5. Roth D. Hepatitis C virus. The nephrologist's view. Am J Kidney Dis 1995: 25: 3.
6. Oguchi H, Miyasaka M, Tokunaga S. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992: 38: 36.
7. Pereira BJ. The impact of pretransplantation hepatitis C infection on outcome of transplantation. N Engl J Med 1992: 327: 910.
8. Mcintyre PG, Mccruden EA, Dow BC. Hepatitis C virus infection in renal dialysis patients in Glasgow. Nephrol Dial Transplant 1994: 9: 291.
9. Covic A, Iancu L, Apetrei C. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999: 14: 40.
10. Mosconi G, Campieri C, Miniero R. Epidemiology of hepatitis C in a population of hemodialysis patients. Nephron 1992: 61: 298.
11. Raccosta G, Merletti MG, Lisi E. Prevalence of hepatitides in our hemodialysed population. Nephron 1992: 61: 300.
12. Corell A, Morales JM, Mandrono A. Immunosuppression induced by hepatitis C virus infection reduces acute renal transplant rejection. Lancet 1995: 346: 1497.
13. Boletis JN, Theodoraki A, Psichogiou M. Immune status in renal transplant recipients with hepatitis C virus infection. Trasplant Proc 2002: 34: 3205.
14. Neto ED, Fonseca JA, De Paula FJ. The impact of azathioprine on chronic viral hepatitis in renal transplantation: A long term single center, prospective study in azathioprine withdrawal. Transplantation 1999: 68: 976.
15. Bestard O, Cruzado JM, Torras J. Long term effect of hepatitis C virus chronic infection on patient and renal graft survival. Transplant Proc 2005: 37: 3774.
16. Kriesche H, Ojo A, Hanson J. Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation 2001: 72: 241.
17. Ruiz P, Gomez F, Schreiber A. Impaired function of macrophage Fcγ receptors in end stage renal disease. N Engl J Med 1990: 322: 717.